Abstract:Objective: To construct an element (HRE-AFPp) containing the hypoxia-induced enhancer (HRE) of the human VEGF gene and promoter of AFP gene ( AFPp) , and to verify the specificity and its activity to hypoxia stimulation. Methods: The DNA segments of AFPp and HRE were synthesized through PCR from human genome DNA. Gene fragments were then cloned into the multiple cloning sites of non-promoter EGFP vector pEGFP-1. The recombinant plasmid was transferred into positive or negative AFP cell lines ( HepG2, SMMC-7721 and Cos-7 ) by means of lipofectamine 2000? The expression of EGFP was tested by fluorescence microscope. The effect of hypoxia treatment on the expression of EGFP was tested by Flow Cytometry. Results: The length, position and orientation of HRE-AFPp were confirmed with restriction digestion and sequence analyses. The expression of EGFP was only detected in AFP-producing tumor cells. The expression rate of EGFP in pEGFP-HRE-AFPp and pEGFP-AFPp transfected HepG2 cells (AFP positive) were 6. 1% and 7.3% , respectively. Cos-7, SMMC-7721 cells (AFP negative) and pEGFP-1, pEGFP-HRE transfected HepG2 cells did not express EGFP. EGFP expression in pEGFP-HRE-AFPp transfected cell line with and without hypoxic treatment were (35.1 ±5.9)% and (12.5 ±3.1)% , respectively (P<0.01); and in pEGFP-AFPp transfected cell line with or without hypoxic treatment were (14.6 ±3. 2) % and (13.4 ± 2. 6) % . The expression of EGFP in pEGFP-HRE-AFPp and pEGFP-AFPp transfected cell lines were significantly different regardless of hypoxia treatment ( P < 0. 01). Conclusion: This recombinant vector constructed in this article can be used as a vector targeting for AFP-producing hepatocellular carcinoma and the activity of genes in this vector can be regulated by hypoxia treatment.

Construction and Identification of an Effective Hypoxia-Inducible Expression Vector

Construction and identification of hypoxia regulatory reporter vectors

Cloning of HRE/CMV Promoters and Determination of Hypoxia Regulatory Activities

[Construction and Identification of a Plasmid with EGFP Reporter Gene for Enhancer Function Analysis].

Construction and verification of a hypoxia-induced gene therapy vector targeting hepatocellular carcinoma

Exploitation of Hypoxia Regulatory Vectors for Gene Therapy of Renal Anemia

Construction and identification of retroviral vector expressing hypoxia-inducible factor-1α and EGFP fusions

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

Construction of a Vector of Luciferase Reporter Gene Directed by VEGF Promoter Mutant

Construction of vector specifically expressed vascular endothelial growth factor gene in endothelial cells and research of its expressive character

Development of a hypoxia-responsive vector for tumor-specific gene therapy

Construction and Identification of Luciferase Reporter Gene Containing Murine IL-12 Promoter and IL-10 Promoter

Construction of Recombinant Eukaryotic Expression Vector Pegfpci-Hif-1α and Its Expression in Eukaryotic Cells PC12

Construction of the vector with human P21 promoter and Dual-Luciferase reporter gene

Construction and Verification of Novel Lentiviral Expression Vector Plox-Cmv-e/p Based on Cre-LoxP System

Construction of recombinant vectors introducing ubiquitous expression or tissue-specific expression in Caenorhabditis elegans

Gene Clone and Construction of Expression Vecter of Hypoxia Inducible Factor-1α in Rats

Establishment of a Cell-Based Assay to Screen Regulators of the Hypoxia-Inducible Factor-1-dependent Vascular Endothelial Growth Factor Promoter.

Construction and identification of eukaryotic expression plasmid of recombinant human hypoxia-inducible factor-1α

Construction of pGL3-Basic-SREBP-1c-promoter reporter gene vector and detection of its function

Construction of a Lentivirus Vector Expressing Three Reporter Genes and Its Experimental Study